The Influence of Glycyrrhetinic Acid on Plasma Cortisol and Cortisone in Healthy Young Volunteers
MARIUS A. MACKENZIE,
WILLIBRORD H. L. HOEFNAGELS,
RENÈ W. M. M. JANSEN,
THEO J. BENRAAD and
PETER W. C. KLOPPENBORG
Department of Medicine, Division of Endocrinology (M.A.M., P.W.C.K.) Nijmegen, The Netherlands
The Departments of Geriatric Medicine (W.H.L.H., R. W.M.M.J.) and Experimental and Chemical Endocrinology (T.J.B.), University Hospital Nijmegen, The Netherlands
Address all correspondence and requests for reprints to: M. A MacKenzie, M.D., Department of Medicine, Division of Endocrinology, University Hospital, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Based on studies in laboratory animals and on measurements ofthe urinary metabolites (allo)tetrahydrocortisol and tetrahydrocortisonein human volunteers it has been claimed that liquorice-inducedmineralocorticoid excess is caused by a unique defect in theconversion of cortisol to cortisone. To further evaluate thishypothesis we have investigated the influence of glycyrrhetinicacid (GA), the mineralocorticoid-active constituent of liquorice,on plasma cortisol and cortisone in 10 healthy young normotensivevolunteers.
Pure GA (500 mg/day), administered orally from days 3-10 ofthe study, exerted pronounced mineralocorticoid activity. Ingestionof GA resulted in an elevated urinary excretion of free cortisoland virtually unchanged plasma cortisol levels in the presenceof markedly decreased levels of both plasma cortisone and urinaryfree cortisone.
These results provide direct clinical support for the hypothesisthat GA induces an inhibition of the activity of 11β-dehydrogenase,resulting in a blockade in the conversion of cortisol to cortisone.
Received November 21, 1989.
This article has been cited by other articles:
I. S. K. Harahap, N. Sasaki, Gunadi, S. Yusoff, M. J. Lee, S. Morikawa, N. Nishimura, T. Sasaki, S. Usuki, M. Hirai, et al. Herbal Medicine Containing Licorice May Be Contraindicated for a Patient With an HSD11B2 Mutation
Evid. Based Complement. Altern. Med.,
December 9, 2009;
(2009)
nep211v1.
[Abstract][Full Text][PDF]
R T Netea-Maier, E J van Lindert, M den Heijer, A van der Eerden, G F F M Pieters, C G J Sweep, J A Grotenhuis, and A R M M Hermus Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease.
Eur. J. Endocrinol.,
May 1, 2006;
154(5):
675 - 684.
[Abstract][Full Text][PDF]
M. Boscaro, L. Barzon, and N. Sonino The Diagnosis of Cushing's Syndrome: Atypical Presentations and Laboratory Shortcomings
Arch Intern Med,
November 13, 2000;
160(20):
3045 - 3053.
[Abstract][Full Text][PDF]
M. B. Feinstein and R. P. Schleimer Regulation of the Action of Hydrocortisone in Airway Epithelial Cells by 11beta -Hydroxysteroid Dehydrogenase
Am. J. Respir. Cell Mol. Biol.,
September 1, 1999;
21(3):
403 - 408.
[Abstract][Full Text]
S. H.M. van Uum, A. R.M.M. Hermus, P. Smits, T. Thien, and J. W.M. Lenders The role of 11{beta}-hydroxysteroid dehydrogenase in the pathogenesis of hypertension
Cardiovasc Res,
April 1, 1998;
38(1):
16 - 24.
[Abstract][Full Text][PDF]
P. C. White, T. Mune, and A. K. Agarwal 11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess
Endocr. Rev.,
February 1, 1997;
18(1):
135 - 156.
[Abstract][Full Text]